Exhaled nitric oxide as a marker for serum nitric oxide concentration in acute endotoxemia

被引:22
|
作者
Hussain, SNA
AbdulHussain, MN
ElDwairi, Q
机构
[1] Critical Care and Resp. Divisions, Royal Victoria Hospital, McGill University, Montreal, Que.
[2] Royal Victoria Hospital, Montreal, Que. H3A 1A1
关键词
D O I
10.1016/S0883-9441(96)90027-1
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Purpose: The main aim of this study was to assess the correlation between exhaled nitric oxide (NO) and serum NO concentrations during the course of endotoxemia. We also assessed whether or not the inducible isoform of NO synthase is responsible for the increase in NO production in endotoxemia animals. Materials and Methods: Anesthetized and mechanically ventilated dogs were injected with either saline (control) or Escherichia coli endotoxin (LPS [Lipopolysaccharides]), and the animals were sacrificed 150 minutes later. We measured hemodynamics, exhaled NO, and serum arterial and mixed venous NO concentrations. Western blotting was performed on lung, pulmonary artery, aorta, and kidney tissue samples using anti-inducible NO synthase antibody. Results: Arterial pressure, cardiac output, and pulmonary arterial pressure in the control group remained unchanged, whereas a significant decline in these parameters was observed in the LPS group. Exhaled NO and serum arterial NO concentrations rose significantly within 30 minutes of endotoxin injection and remained higher than baseline values, whereas mixed venous serum NO did not change from baseline values. There was a significant linear relationship between exhaled NO and arterial serum NO concentrations. By comparison, exhaled NO, and arterial and mixed venous serum NO levels remained unchanged in the control group. Western blotting showed no expression of inducible NO synthase (iNOS) isoform in the control or LPS groups. Conclusions: These results suggest that exhaled NO accurately reflects changes in arterial serum NO concentration and that the source of enhanced NO release in acute endotoxemia is not the iNOS isoform. Copyright (C) 1996 by W.B. Saunders Company
引用
收藏
页码:167 / 175
页数:9
相关论文
共 50 条
  • [21] Exhaled nitric oxide as a marker of asthma control in smoking patients
    Michils, A.
    Louis, R.
    Peche, R.
    Baldassarre, S.
    Van Muylem, A.
    EUROPEAN RESPIRATORY JOURNAL, 2009, 33 (06) : 1295 - 1301
  • [22] Exhaled Nitric Oxide As A Possible Marker For Remodeling In Mild Asthmatics?
    Nihlberg, K.
    Larsson, A.
    Tufvesson, E.
    Bjermer, L.
    Westergren-Thorsson, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [23] Exhaled Nitric Oxide in COPD
    Bikov, Andras
    Meszaros, Martina
    Lazar, Zsofia
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2019, 15 (02) : 71 - 78
  • [24] Measurement of Exhaled Nitric Oxide
    Oguzulgen, I. Kivilcim
    TURKISH THORACIC JOURNAL, 2013, 14 : 37 - 40
  • [25] Exhaled nitric oxide and atopy
    Gratziou, C
    DISEASE MARKERS IN EXHALED BREATH: BASIC MECHANISMS AND CLINICAL APPLICATIONS, 2002, 346 : 191 - 195
  • [26] Caffeine and exhaled nitric oxide
    Thomas, PS
    Yates, DH
    Bruce, C
    THORAX, 2003, 58 (03) : 281 - 281
  • [27] Exhaled nitric oxide and atherosclerosis
    Salonen, Iiris
    Huttunen, Kati
    Hirvonen, Maija-Riitta
    Dufva, Juhani
    Groundstroem, Kaj
    Dufva, Hilkka
    Salonen, Raimo O.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2012, 42 (08) : 873 - 880
  • [28] Exhaled nitric oxide in sarcoidosis
    Wilsher, ML
    Fergusson, W
    Milne, D
    Wells, AU
    THORAX, 2005, 60 (11) : 967 - 970
  • [29] Exhaled and nasal nitric oxide as a marker of pneumonia in ventilated patients
    Adrie, C
    Monchi, M
    Dinh-Xuan, AT
    Dall'Ava-Santucci, J
    Dhainaut, JF
    Pinsky, MR
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 163 (05) : 1143 - 1149
  • [30] Exhaled nitric oxide An emerging marker of inflammation in respiratory diseases
    Habib, Syed S.
    SAUDI MEDICAL JOURNAL, 2008, 29 (12) : 1697 - 1702